If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Antonia Martinetti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Neuroendocrine Tumors Medicine & Life Sciences
Aromatase Inhibitors Medicine & Life Sciences
exemestane Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Serum Medicine & Life Sciences
letrozole Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

  • 2318 Citations
  • 28 h-Index
  • 92 Article
  • 1 Review article
12 Citations (Scopus)

Circulating miRNAs and PD-L1 tumor expression are associated with survival in advanced NSCLC patients treated with immunotherapy: A prospective study

Boeri, M., Milione, M., Proto, C., Signorelli, D., Russo, G. L., Galeone, C., Verri, C., Mensah, M., Centonze, G., Martinetti, A., Sottotetti, E., Pastorino, U., Garassino, M. C. & Sozzi, G., Apr 1 2019, In : Clinical Cancer Research. 25, 7, p. 2166-2173 8 p.

Research output: Contribution to journalReview article

MicroRNAs
Non-Small Cell Lung Carcinoma
Immunotherapy
Prospective Studies
Survival
Open Access
Circulating Neoplastic Cells
Castration
Prostatic Neoplasms
Androgen Receptors
Disease-Free Survival

Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?

Nichetti, F., Falvella, F. S., Miceli, R., Cheli, S., Gaetano, R., Fucà, G., Infante, G., Martinetti, A., Antoniotti, C., Falcone, A., Di Bartolomeo, M., Cremolini, C., de Braud, F. & Pietrantonio, F., Oct 1 2019, In : Pharmacogenomics Journal. 19, 5, p. 465-472 8 p.

Research output: Contribution to journalArticle

oxaliplatin
Pharmacogenetics
Colorectal Neoplasms
Single Nucleotide Polymorphism

Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial

Platania, M., Pasini, F., Porcu, L., Boeri, M., Verderame, F., Modena, Y., Del Conte, A., Nichetti, F., Garassino, M. C., Martinetti, A., Sottotetti, E., Cavanna, L., Vattemi, E., Pozzessere, D., Bertolini, A., Irtelli, L., Verri, C., Sozzi, G., Proto, C., Pastorino, U. & 12 others, Torri, V., Fraccon, A. P., Spinnato, F., Signorelli, D., Lo Russo, G., Tuzi, A., Gallucci, R., Cinieri, S., Mencoboni, M., Antonelli, P., Giacomelli, L. & de Braud, F., Jun 2019, In : Lung Cancer. 132, p. 17-23 7 p.

Research output: Contribution to journalArticle

Platinum
Non-Small Cell Lung Carcinoma
Maintenance
Drug Therapy
Disease-Free Survival

Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase

Schwartz, S., Szeto, C., Tian, Y., Cecchi, F., Corallo, S., Calegari, M. A., Di Bartolomeo, M., Morano, F., Raimondi, A., Fucà, G., Martinetti, A., De Pascalis, I., Martini, M., Belfiore, A., Milione, M., Orlandi, A., Barault, L., Barone, C., de Braud, F., Di Nicolantonio, F. & 3 others, Benz, S., Hembrough, T. & Pietrantonio, F., Jan 1 2019, In : European Journal of Cancer. 107, p. 164-174 11 p.

Research output: Contribution to journalArticle

temozolomide
Methyltransferases
Proteomics
Patient Selection
Colorectal Neoplasms